©The Author(s) 2026.
World J Gastrointest Surg. Jan 27, 2026; 18(1): 114570
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114570
Published online Jan 27, 2026. doi: 10.4240/wjgs.v18.i1.114570
Table 5 Comparisons of demographic and clinical data between the open low anterior resection surgery and laparoscopic low anterior resection surgery groups, n (%)
| Variables | Open surgery group (n = 63) | Laparoscopic surgery group (n = 42) | P value |
| Age (years) (mean ± SD) | 66.62 ± 12 | 65.45 ± 9.9 | 0.62 |
| Gender, female/male | 19/44 (30.2/69.8) | 20/22 (47.6/52.4) | 0.07 |
| Diabetes mellitus | 19 (30.2) | 6 (14.3) | 0.06 |
| Smoking | 13 (20.6) | 9 (21.4) | 0.92 |
| Body mass index (kg/m2, mean ± SD) | 24.05 ± 2.3 | 24.36 ± 2.1 | 0.49 |
| Operating time (minutes) (mean ± SD) | 274.13 ± 59 | 286.55 ± 57 | 0.29 |
| Length of hospital stay (days) (mean ± SD) | 10.97 ± 5.2 | 8.64 ± 2.9 | 0.011 |
| Follow-up period (months) (mean ± SD) | 48.83 ± 25 | 42.86 ± 25 | 0.24 |
| Disease-free survival (months) (mean ± SD) | 43.83 ± 26 | 40.48 ± 22 | 0.50 |
| Removed LAP count (mean ± SD) | 16.48 ± 6.4 | 16.98 ± 7.3 | 0.71 |
| Metastasis LAP count (mean ± SD) | 1.89 ± 2.9 | 1.12 ± 2.5 | 0.17 |
| Stage classification | 0.05 | ||
| Stage 0 | 0 (0) | 1 (2.4) | |
| Stage 1 | 13 (20.6) | 13 (31) | |
| Stage 2 | 16 (25.4) | 16 (38.1) | |
| Stage 3 | 34 (54) | 12 (28.6) | |
| Mass localization level | 0.65 | ||
| Lower | 8 (12.7) | 6 (14.3) | |
| Middle | 17 (27) | 8 (19) | |
| Upper | 38 (60.3) | 28 (66.7) | |
| Protective loop ileostomy | 12 (19) | 11 (26.2) | 0.38 |
| Neoadjuvant chemoradiotherapy | 13 (20.6) | 13 (31) | |
| Preoperative albumin (g/L) (mean ± SD) | 31.4 ± 5.6 | 32.6 ± 4.4 | 0.25 |
| Hemoglobin (g/dL) | |||
| Preoperative (mean ± SD) | 11.42 ± 2.1 | 11.62 ± 1.8 | 0.61 |
| Postoperative day 1 (mean ± SD) | 10.93 ± 1.2 | 10.55 ± 1.1 | 0.92 |
| Neutrophil/Lymphocyte ratio | |||
| Preoperative (mean ± SD) | 4.9 ± 2.6 | 5.8 ± 2.8 | 0.09 |
| Postoperative day 1 (mean ± SD) | 10.6 ± 3.8 | 10.7 ± 5.7 | 0.96 |
| Postoperative day 3 (mean ± SD) | 8.3 ± 4.1 | 7.8 ± 3.8 | 0.49 |
| Eosinophil/Lymphocyte ratio | |||
| Preoperative (mean ± SD) | 0.12 ± 0.1 | 0.14 ± 0.01 | 0.52 |
| Postoperative day 1 (mean ± SD) | 0.006 ± 0.01 | 0.954 ± 0.22 | 0.003 |
| Postoperative day 3 (mean ± SD) | 0.11 ± 0.1 | 0.24 ± 0.2 | 0.003 |
| Lymphocyte/monocyte ratio | |||
| Preoperative (mean ± SD) | 3.4 ± 1.7 | 2.7 ± 1.2 | 0.016 |
| Postoperative day 1 (mean ± SD) | 2.1 ± 1.6 | 1.6 ± 0.5 | 0.08 |
| Postoperative day 3 (mean ± SD) | 2.4 ± 0.8 | 2.3 ± 0.8 | 0.52 |
| Prognostic nutritional index score (mean ± SD) | 38.44 ± 6.8 | 38.84 ± 5.3 | 0.75 |
| Early complications | 23 (36.5) | 6 (14.3) | 0.01 |
| Late complications | 0.87 | ||
| None | 54 (85.7) | 37 (88.1) | |
| Bridge ileus | 1 (1.6) | 0 (0) | |
| Anastomosis narrowing | 5 (7.9) | 3 (7.1) | |
| Recurrence | 3 (4.8) | 2 (4.8) | |
| Disease course | 0.02 | ||
| Remission | 40 (63.5) | 36 (85.7) | |
| Progression | 9 (14.3) | 4 (9.5) | |
| Mortality | 14 (22.2) | 2 (4.8) |
- Citation: Taşkin AK, Akar M, Turgut MS, Bilir B, Karademir E. Preoperative clinical and laboratory factors associated with early complications after low anterior resection: Exploratory analysis of the eosinophil/lymphocyte ratio. World J Gastrointest Surg 2026; 18(1): 114570
- URL: https://www.wjgnet.com/1948-9366/full/v18/i1/114570.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v18.i1.114570